Evidence map›Paper›PMID 31176362›Full record

ArticleBMC medical research methodology2019

Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands.

Cornelia D van Steenbeek, Marissa C van Maaren, Sabine Siesling, Annemieke Witteveen, Xander A A M Verbeek, Hendrik Koffijberg

Open access · goldAbstract read
In one paragraph

Article in BMC medical research methodology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Cornelia D van SteenbeekDepartment of Research, Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, Utrecht, DT, 3511, The Netherlands.
Marissa C van MaarenDepartment of Research, Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, Utrecht, DT, 3511, The Netherlands. m.vanmaaren@iknl.nl.ORCID 0000-0002-5708-2559
Sabine SieslingDepartment of Research, Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, Utrecht, DT, 3511, The Netherlands.
Annemieke WitteveenDepartment of Research, Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, Utrecht, DT, 3511, The Netherlands.
Xander A A M VerbeekDepartment of Research, Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, Utrecht, DT, 3511, The Netherlands.
Hendrik KoffijbergDepartment of Health Technology & Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Drienerlolaan 5, Enschede, NB, 7522, The Netherlands. h.koffijberg@utwente.nl.
Netherlands Comprehensive Cancer Organisation · NLUniversity of Twente · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClinical prediction models are not routinely validated. To facilitate validation procedures, the online Evidencio platform ( https://www.evidencio.com ) has developed a tool partly automating this process. This study aims to determine whether semi-automated validation can reliably substitute manual validation.

methodsFour different models used in breast cancer care were selected: CancerMath, INFLUENCE, Predicted Probability of Axillary Metastasis, and PREDICT v.2.0. Data were obtained from the Netherlands Cancer Registry according to the inclusion criteria of the original development population. Calibration (intercepts and slopes) and discrimination (area under the curve (AUC)) were compared between semi-automated and manual validation.

resultsDifferences between intercepts and slopes of all models using semi-automated validation ranged from 0 to 0.03 from manual validation, which was not clinically relevant. AUCs were identical for both validation methods.

conclusionsThis easy to use semi-automated validation option is a good substitute for manual validation and might increase the number of validations of prediction models used in clinical practice. In addition, the validation tool was considered to be user-friendly and to save a lot of time compared to manual validation. Semi-automated validation will contribute to more accurate outcome predictions and treatment recommendations in the target population.

Indexed as

Validation Studies as TopicArea Under CurveBreast NeoplasmsDatabases, FactualFemaleHumansModels, BiologicalNetherlandsPrognosisRegistriesBreast cancerExternal validationPrediction modelsSemi-automated

Identifiers

PMID31176362
PMCPMC6556016
OpenAlexW2948728823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.